Cargando…

Adenosine, bridging chronic inflammation and tumor growth

Adenosine (Ado) is a well-known immunosuppressive agent that may be released or generated extracellularly by cells, via degrading ATP by the sequential actions of the ectonucleotides CD39 and CD73. During inflammation Ado is produced by leukocytes and tissue cells by different means to initiate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Luxia, Alabdullah, Mohamad, Mahnke, Karsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643868/ https://www.ncbi.nlm.nih.gov/pubmed/38022572 http://dx.doi.org/10.3389/fimmu.2023.1258637

Ejemplares similares

ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity
por: Silva-Vilches, Cinthia, et al.
Publicado: (2018)

The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells
por: Da, Meihong, et al.
Publicado: (2022)

Regulation of Inflammation by Adenosine
por: Haskó, György, et al.
Publicado: (2013)

Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury
por: Li, Xiangyun, et al.
Publicado: (2021)

Mast Cell Adenosine Receptors Function: A Focus on the A3 Adenosine Receptor and Inflammation
por: Rudich, Noam, et al.
Publicado: (2012)

Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives
por: de Andrade Mello, Paola, et al.
Publicado: (2017)

Adenosine pathway regulates inflammation during Plasmodium vivax infection
por: Diniz, Suelen Queiroz, et al.
Publicado: (2023)

Antibody Targeting of “Steady-State” Dendritic Cells Induces Tolerance Mediated by Regulatory T Cells
por: Mahnke, Karsten, et al.
Publicado: (2016)

A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
por: Ohta, Akio
Publicado: (2016)

Commentary: A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
por: Vaupel, Peter, et al.
Publicado: (2016)

Methotrexate attenuates vascular inflammation through an adenosine-microRNA-dependent pathway
por: Yang, Dafeng, et al.
Publicado: (2021)

Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine
por: Vaupel, Peter, et al.
Publicado: (2017)

Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes
por: Ding, Qiyou, et al.
Publicado: (2022)

Tumor accomplice: T cell exhaustion induced by chronic inflammation
por: Fang, Liguang, et al.
Publicado: (2022)

Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer
por: Kowash, Ryan R., et al.
Publicado: (2023)

The immunomodulatory function of adenosine in sepsis
por: Zhang, Teng, et al.
Publicado: (2022)

Creatine supplementation enhances anti-tumor immunity by promoting adenosine triphosphate production in macrophages
por: Peng, Zhenzi, et al.
Publicado: (2023)

Adenosine A2A Receptor Suppressed Astrocyte-Mediated Inflammation Through the Inhibition of STAT3/YKL-40 Axis in Mice With Chronic Cerebral Hypoperfusion-induced White Matter Lesions
por: Yuan, Jichao, et al.
Publicado: (2022)

Corrigendum: Adenosine A2A Receptor Suppressed Astrocyte-Mediated Inflammation through the Inhibition of STAT3/YKL-40 Axis in Mice with Chronic Cerebral Hypoperfusion-Induced White Matter Lesions
por: Yuan, Jichao, et al.
Publicado: (2022)

Adenosine signaling: Optimal target for gastric cancer immunotherapy
por: Wang, Junqing, et al.
Publicado: (2022)

STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
por: Sauer, Merle, et al.
Publicado: (2022)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Extracellular Adenosine-Mediated Modulation of Regulatory T Cells
por: Ohta, Akio, et al.
Publicado: (2014)

Inflammatory Bowel Diseases: It's Time for the Adenosine System
por: Antonioli, Luca, et al.
Publicado: (2020)

Extracellular cAMP-Adenosine Pathway Signaling: A Potential Therapeutic Target in Chronic Inflammatory Airway Diseases
por: Pacini, Enio Setsuo Arakaki, et al.
Publicado: (2022)

Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
por: Yu, Weihua, et al.
Publicado: (2022)

Autoimmune Dysregulation and Purine Metabolism in Adenosine Deaminase Deficiency
por: Sauer, Aisha Vanessa, et al.
Publicado: (2012)

Adenosine Deaminase Deficiency – More Than Just an Immunodeficiency
por: Whitmore, Kathryn V., et al.
Publicado: (2016)

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
por: Vigano, Selena, et al.
Publicado: (2019)

Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
por: Wei, Qi, et al.
Publicado: (2022)

Anti-inflammatory Effects of Heme Oxygenase-1 Depend on Adenosine A(2A)- and A(2B)-Receptor Signaling in Acute Pulmonary Inflammation
por: Konrad, Franziska M., et al.
Publicado: (2017)

Chronic Inflammation in Cancer Development
por: Multhoff, Gabriele, et al.
Publicado: (2012)

Chronic Inflammation and γδ T Cells
por: Fay, Nathan S., et al.
Publicado: (2016)

Precision Nutrition in Chronic Inflammation
por: Demetrowitsch, Tobias J., et al.
Publicado: (2020)

Soluble Ecto-5′-nucleotidase (5′-NT), Alkaline Phosphatase, and Adenosine Deaminase (ADA1) Activities in Neonatal Blood Favor Elevated Extracellular Adenosine
por: Pettengill, Matthew, et al.
Publicado: (2013)

Adenosine-A2A Receptor Pathway in Cancer Immunotherapy
por: Sun, Changfa, et al.
Publicado: (2022)

Reversal of the CD8(+) T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways
por: Li, Jing, et al.
Publicado: (2021)

Inflammation and histone modification in chronic pain
por: Jiang, Wei, et al.
Publicado: (2023)

The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer
por: Zohair, Basma, et al.
Publicado: (2023)

The molecular mechanisms of chronic inflammation development
por: Murakami, Masaaki, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1ovd9ot4ig19t2bub4m8lb4llr